|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2007-2-5
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
The objective of this study was to test the effect of a 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitor on the progression of moderate to severe aortic stenosis as measured by echocardiography.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1558-3597
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
6
|
|
pubmed:volume |
49
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
554-61
|
|
pubmed:dateRevised |
2011-10-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17276178-Aged,
pubmed-meshheading:17276178-Aged, 80 and over,
pubmed-meshheading:17276178-Antigens, CD40,
pubmed-meshheading:17276178-Aortic Valve,
pubmed-meshheading:17276178-Aortic Valve Stenosis,
pubmed-meshheading:17276178-Blood Flow Velocity,
pubmed-meshheading:17276178-C-Reactive Protein,
pubmed-meshheading:17276178-Cohort Studies,
pubmed-meshheading:17276178-Echocardiography,
pubmed-meshheading:17276178-Female,
pubmed-meshheading:17276178-Fluorobenzenes,
pubmed-meshheading:17276178-Humans,
pubmed-meshheading:17276178-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:17276178-Interleukin-6,
pubmed-meshheading:17276178-Lipids,
pubmed-meshheading:17276178-Male,
pubmed-meshheading:17276178-Pyrimidines,
pubmed-meshheading:17276178-Severity of Illness Index,
pubmed-meshheading:17276178-Sulfonamides,
pubmed-meshheading:17276178-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis.
|
|
pubmed:affiliation |
Hospital Pedro Hispano, Matosinhos, Portugal.
|
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial
|
